Akademska digitalna zbirka SLovenije - logo
E-resources
Peer reviewed Open access
  • Variability in physician pr...
    Zahuranec, Darin B; Fagerlin, Angela; Sánchez, Brisa N; Roney, Meghan E; Thompson, Bradford B; Fuhrel-Forbis, Andrea; Morgenstern, Lewis B

    Neurology, 2016-May-17, 2016-05-17, 20160517, Volume: 86, Issue: 20
    Journal Article

    OBJECTIVE:To assess physician prognosis and treatment recommendations for intracerebral hemorrhage (ICH) and to determine the effect of providing physicians a validated prognostic score. METHODS:A written survey with 2 ICH scenarios was completed by practicing neurologists and neurosurgeons. Selected factors were randomly varied (patient older vs middle age, Glasgow Coma Scale GCS score 7T vs 11, and presence vs absence of a validated prognostic score). Outcomes included predicted 30-day mortality and recommendations for initial treatment intensity (6-point scale ranging from 1 = comfort only to 6 = full treatment). RESULTS:A total of 742 physicians were included (mean age 52, 32% neurosurgeons, 17% female). Physician predictions of 30-day mortality varied widely (mean range for the 4 possible combinations of age and GCS were 23% 0%–80%, 35% 0%–100%, 48% 0%–100%, and 58% 5%–100%). Treatment recommendations also varied widely, with responses encompassing the full range of response options for each case. No physician demographic or personality characteristics were associated with treatment recommendations. Providing a prognostic score changed treatment recommendations, and the effect differed across cases. When the prognostic score suggested 0% chance of functional independence (76-year-old with GCS 7T), the likelihood of treatment limitations was increased (odds ratio OR 1.61, 95% confidence interval CI 1.12–2.33) compared to no prognostic score. Conversely, if the score suggested a 66% chance of independence (63-year-old with GCS 11), treatment limitations were less likely (OR 0.62, 95% CI 0.43–0.88). CONCLUSIONS:Physicians vary substantially in ICH prognostic estimates and treatment recommendations. This variability could have a profound effect on life and death decision-making and treatment for ICH.